Jeff was previously employed as President and Chief Executive Officer of Genomic Solutions Inc., an Ann Arbor-based life science instrumentation company he co-founded in 1997. He led Genomic Solutions through a period of rapid growth culminating in an IPO on Nasdaq in 2000 and merger with Harvard Biosciences, Inc. in late 2002. After the merger, Jeff remained with Genomic Solutions as its President and joined the Harvard Board of Directors.

Prior to Genomic Solutions, Jeff was Chief Operating Officer of International Remote Imaging Systems (IRIS), a publicly-traded, California-based company specializing in digital imaging for the clinical diagnostic and research markets. Prior to IRIS, he spent approximately five years at Boehringer Mannheim (now part of Hoffman LaRoche), a $4 billion healthcare company with interests in clinical diagnostics, orthopedics, therapeutics, and research chemicals. In his last position at Boehringer, Jeff was located in the company's global headquarters in Mannheim, Germany, where he served as Vice President and Global Business Manager for a $100+ million clinical diagnostic business. Jeff held previous positions with Boehringer in general management, strategic planning and marketing. Prior to Boehringer, he was employed in the Organon Pharmaceutical division of Akzo Nobel. Jeff received a B.S. in Biology (summa cum laude) from Alma College and an MBA with high distinction from the University of Michigan.